Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126538) titled 'Construction and Validation of an Intelligent Auxiliary Diagnostic Model for Pancreatic Cancer Gene Mutations Based on Contrast-Enhanced CT' on June 10.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Fudan University Shanghai Cancer Center
Condition:
pancreatic cancer
Intervention:
Gold Standard:Gene mutation detection
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2026-06-12
Target Sample Size: Target condition:300;Difficult condition:0
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=...